Distalmotion announced today that it submitted a 510(k) application to the FDA to expand indications for its Dexter surgical ...
The company is seeking clearance in additional gynecological indications to support outpatient use of its surgical robot.
Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, announced that it submitted a 510(k) application to the US Food and Drug Administration (FDA) ...
Distalmotion’s Dexter surgical robotics system challenges the clinical and economic barriers that limit ambulatory surgical ...
Lausanne, Switzerland, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results